C3a



C3a

S1SS1V2VV2Q3QQ3L4LL4T5TT5E6EE6K7KK7R8RR8M9MM9D10DD10K11KK11V12VV12G13GG13K14KK14Y15YY15P16PP16K17KK17E18EE18L19LL19R20RR20K21KK21C22CC22C23CC23E24EE24D25DD25G26GG26M27MM27R28RR28E29EE29N30NN30P31PP31M32MM32R33RR33F34FF34S35SS35C36CC36Q37QQ37R38RR38R39RR39T40TT40R41RR41F42FF42I43II43S44SS44L45LL45G46GG46E47EE47... and 30 more residue(s)...... and 30 more residue(s)

SMILES None
InChIKey None
Sequence SVQLTEKRMDKVGKYPKELRKCCEDGMRENPMRFSCQRRTRFISLGEACKKVFLDCCNYITELRRQHARASHLGLAR

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

C3a

S1SS1V2VV2Q3QQ3L4LL4T5TT5E6EE6K7KK7R8RR8M9MM9D10DD10K11KK11V12VV12G13GG13K14KK14Y15YY15P16PP16K17KK17E18EE18L19LL19R20RR20K21KK21C22CC22C23CC23E24EE24D25DD25G26GG26M27MM27R28RR28E29EE29N30NN30P31PP31M32MM32R33RR33F34FF34S35SS35C36CC36Q37QQ37R38RR38R39RR39T40TT40R41RR41F42FF42I43II43S44SS44L45LL45G46GG46E47EE47... and 30 more residue(s)...... and 30 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.